CATALYST PHARMACEUTICALS INC (CPRX) Stock Income Statement
USA - NASDAQ:CPRX - US14888U1016 - Common Stock
22.4 USD
-0.26 (-1.15%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 558.50M | 491.73M | 398.20M | 214.20M | 140.80M | |||
| Gross Premiums Earned | null | null | null | null | null | |||
| Loss Claims | null | null | null | null | null | |||
| Deferred Policy Acquisition Expense | null | null | null | null | null | |||
| Net Interest Income | null | null | null | null | null | |||
| Non Interest Income | null | null | null | null | null | |||
| Loan Loss Provision | null | null | null | null | null | |||
| Net Interest Income after Provision | null | null | null | null | null | |||
| Non Interest Expense | null | null | null | null | null | |||
| Minority Interest Expense | null | null | null | null | null | |||
| Cost Of Goods | 80.00M | 69.00M | 52.00M | 34.40M | 21.90M | |||
| Gross Profit | 479.05M | 422.89M | 346.24M | 179.80M | 118.90M | |||
| Operating Expenses | 235.00M | 228.00M | 259.00M | 78.00M | 66.50M | |||
| Research and Development | 15.33M | 12.65M | 93.15M | 19.80M | 16.90M | |||
| Selling, General, and Administrative Expenses | 183.00M | 178.00M | 134.00M | 58.20M | 49.60M | |||
| Operating Income | 243.00M | 195.00M | 87.00M | 101.80M | 52.40M | |||
| Interest Income/Expense | null | null | null | null | null | |||
| Other Income/Expense | 28.22M | 21.00M | 7.70M | 2.90M | 300.00K | |||
| Non Recurring Items | null | null | null | null | null | |||
| Income Before Taxes | 271.00M | 216.00M | 95.00M | 104.70M | 52.70M | |||
| Income Tax | 63.00M | 52.00M | 23.00M | 21.60M | 13.20M | |||
| Net Income | 209.00M | 164.00M | 71.00M | 83.10M | 39.50M | |||
| EBITDA | 280.83M | 232.78M | 119.89M | 103.00M | 52.60M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 1.65 | 1.31 | 0.63 | 0.75 | 0.37 | |||
| Non GAAP EPS | 1.65 | 1.31 | 0.81 | 0.7400000000000001 | 0.37 | |||
| Statistics | ||||||||
| Gross Profit Margin | 85.78% | 86.00% | 86.95% | 83.94% | 84.45% | |||
| Profit Margin | 37.42% | 33.35% | 17.83% | 38.80% | 28.05% | |||
| Operating Profit Margin | 43.51% | 39.66% | 21.85% | 47.53% | 37.22% | |||
All data in USD